What do systematic reviews say?

Intervention not reported

It is very uncertain whether the intervention changes adverse events: fatigue (very low certainty).

• Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission 2015 · Cochrane Headline outcomes only
  RR 7.05 [2.13, 23.36]
  1 study · 528 participants
  Very low